2017 | Professor Ketan Dhatariya

Liraglutide impact on diabetic foot ulcers in people with type 2 diabetes at increased risk of cardiovascular events – LEADER trial

by Ketan Dhatariya | Sep 30, 2017 | 2017, Abstracts

Dhatariya K, Bain SC, Pratley RE, Buse JB, Simpson R, Tarnow L, Stellfield M, Kaloft MS, Tornoe K. International Diabetes Federation meeting Abu Dhabi December...

Hurthle Cell Tumour – A case of delayed metastatic disease causing abnormal thyroid function, acromegaly & hypercalcaemia

by Ketan Dhatariya | Sep 30, 2017 | 2017, Abstracts

Ur Rehman S, Roques T, Turner J, Dhatariya K. Multidisciplinary Endocrine Symposium meeting, Hammersmith Hospital, December...

First estimates of the cost of treating diabetic ketoacidosis in the UK – International Society for Pharmacoeconomics and Outcomes. Glasgow November 2017

by Ketan Dhatariya | Sep 30, 2017 | 2017, Abstracts

Dhatariya KK, Skedgel C, Fordham...

Does assessment and management for QTc prolongation on 12 lead ECG in the diabetes foot clinic reduce mortality?

by Ketan Dhatariya | Sep 30, 2017 | 2017, Abstracts

Valabhji J, Collins N, Young RJ, Nayar R, Rajbhandari S, Coppini D, Manu C, Dhatariya K, Gooday C, Kong MF, Ashwell S, Nayak A, Robinson A, Gray H, Holman N, Edmonds...

Exploring the impact of liraglutide on diabetic foot ulcers in patients with type 2 diabetes and increased risk of cardiovascular events: results from the LEADER trial.

by Ketan Dhatariya | Sep 30, 2017 | 2017, Abstracts

Dhatariya K, Bain SC, Partly RE, Bush JB, Simpson R, Tarnow L, Stellfeld M, Kaltoft MS, Torno K. Presented at the EASD September...

Glycaemic Variability As Measured By The Magnitude Of Change Of Visit To Visit HbA1c Concentrations Over The 5 Years Prior To Presentation, Is Significantly Associated With Rate Of Wound Healing In The Diabetic Foot

by Ketan Dhatariya | Sep 30, 2017 | 2017, Abstracts

Li Ping Wah-Pun Sin E, Cheng J, Li F, Yue A, Gooday C, Nunney I, Dhatariya K. DFSG, Porto...

PROFESSOR KETAN DHATARIYA

Consultant in Diabetes, Endocrinology & General Medicine

Liraglutide impact on diabetic foot ulcers in people with type 2 diabetes at increased risk of cardiovascular events – LEADER trial

Hurthle Cell Tumour – A case of delayed metastatic disease causing abnormal thyroid function, acromegaly & hypercalcaemia

First estimates of the cost of treating diabetic ketoacidosis in the UK – International Society for Pharmacoeconomics and Outcomes. Glasgow November 2017

Does assessment and management for QTc prolongation on 12 lead ECG in the diabetes foot clinic reduce mortality?

Exploring the impact of liraglutide on diabetic foot ulcers in patients with type 2 diabetes and increased risk of cardiovascular events: results from the LEADER trial.

Glycaemic Variability As Measured By The Magnitude Of Change Of Visit To Visit HbA1c Concentrations Over The 5 Years Prior To Presentation, Is Significantly Associated With Rate Of Wound Healing In The Diabetic Foot

Recent Posts